Wolf-Dieter Ludwig

Wolf-Dieter Ludwig

Wolf-Dieter Ludwig (* 1952 in Munich ) is a German specialist in internal medicine and pharmacologist , specializing in hematology , internal oncology and transfusion medicine . From 2001 to 2017 he was the chief physician and chief physician at the HELIOS Clinic Berlin-Buch and is professor of internal medicine. He has been a full member of the Medicines Commission of the German Medical Association since 1999, has been a member of the board since 2000 and has been elected chairman since 2006.

Live and act

Wolf-Dieter Ludwig was born in Munich. His father was the well-known tenor Walther Ludwig . The family lived in Berlin because the Städtische Oper Berlin had signed him as First Lyric Tenor. The son put here in 1971 at the Droste-Hulshoff High School in Berlin-Zehlendorf the High School from. In Zehlendorf he was involved in football, won the championship of the Berlin Regional Football League with Hertha Zehlendorf's juniors and took part in the promotion to the Bundesliga.

After graduating from high school, he began studying human medicine in Leuven ( Belgium ), which he continued in Frankfurt am Main and Innsbruck ( Austria ) and successfully completed in Berlin at the Free University of Berlin (FU).

He started his career in 1979 as a research assistant at the Pharmacological Institute of the Free University in Berlin. In 1981 he moved to the Steglitz University Hospital of the Free University of Berlin in the department of internal medicine specializing in hematology and oncology . During this time he wrote his dissertation and obtained his doctorate in medicine ( Dr. med. ) At the Free University of Berlin in 1982 .

In 1988 he became senior physician in this department for internal medicine specializing in hematology and oncology at the Steglitz University Hospital. During this time he wrote his habilitation thesis , with which he obtained the academic degree Dr. med. habil. as well as has acquired the teaching license.

From 1993 to 2001 he was senior physician in charge and deputy director of the medical clinic specializing in hematology, oncology and tumor immunology at the Robert Rössle Clinic , Charité , Berlin-Buch campus , Humboldt University Berlin . In 1994 he was appointed C3 professor for internal medicine (hematology, oncology and applied molecular biology) in the Department of the University Hospital Rudolf-Virchow , Berlin-Buch.

In 2001 he moved to the HELIOS Clinic Berlin-Buch , Robert-Rössle-Klinik, to the position of chief physician of the medical clinic (hematology, oncology and tumor immunology). In 2006 he was elected chairman of the Drugs Commission of the German Medical Association and, after being re-elected several times, will hold this position for 3 years each (most recently at the end of 2018) until the end of 2021.

From 2009 he took over the position of chief physician at the clinic for hematology, oncology, tumor immunology and palliative medicine . In 2017/2018 he carried out an outpatient activity at the outpatient clinic at the HELIOS Klinikum Berlin-Buch, and since 2019 in the focus practice hematology and oncology in Berlin-Mitte .

Focus of work

In the clinical area , Wolf-Dieter Ludwig focuses on a number of areas: acute leukemia; malignant lymphomas; multiple myeloma; supportive therapy strategies for hematological neoplasms; Use of blood products (hemotherapy); rational pharmacotherapy in hematology / internal oncology; Avoidance of over-therapy at the end of life as well as precision medicine.

His scientific work focuses on the characterization of cell biological features of acute leukemia (immune phenotype, molecular genetic changes) as a basis for risk-adapted therapy decisions, the regulation of apoptosis and gene expression analyzes in acute leukemia, drug therapy safety and the handling of conflicts of interest in medicine.

Memberships and functions (selection)

• since 1988 member of various national and international specialist societies such as the German Society for Hematology and Oncology; German Society for Immunology; German Society for Pediatric Oncology; European Hematology Association; American Society of Hematology et al
• since 1991 employee of the independent information sheet "Der Arzneimittelbrief", since 1996 member of the editorial board and since 2006 co-editor
• 1999–2006 member of the blood working group, subgroup "Evaluation of blood-associated pathogens" at the Paul Ehrlich Institute in Langen
• 2003–2005 Chairman of the Off-Label Expert Group at the Federal Institute for Drugs and Medical Devices
• since 2006 specialist editor for the field of "internal medicine, hematology and drug therapy" of the medical-scientific editorial team of Deutsches Ärzteblatt
• since 2006 elected chairman of the drug commission of the German medical profession in Berlin
• since 2013 member of the management board of the European Medicines Agency (EMA) as representative of the European medical community
• since 2016 member of the scientific advisory board of the Medical Center for Quality in Medicine (ÄZQ)
• Member of the scientific advisory board for the Rx Trend Report (ZI) since 2018.

Publications (selection)

• Klaus Lieb, David Klemperer, Wolf-Dieter Ludwig (eds.): Conflicts of interest in medicine. Background and possible solutions. Springer-Verlag, Berlin; Heidelberg 2011.
• Wolf-Dieter Ludwig with a contribution by Stanislava Dicheva-Radev: Care focus on oncology. Pro Generika, Berlin 2019.

literature

• Peter Oehme , Silke Oßwald: Report on the Leibniz Forum "Possibilities, limits and perspectives of individualized medicine using the example of oncology" (keynote lecture by Wolf-Dieter Ludwig on the subject of "Individualized medicine between promise and reality"). March 10, 2016 in Berlin ( [1] ).

Web links

• Literature by and about Wolf-Dieter Ludwig in the catalog of the German National Library
• Website of the drug commission of the German medical profession [2]

Individual evidence

1. ↑ This commission is relevant because it is its task to independently advise the German Medical Association on all scientific questions relating to pharmaceuticals and at the same time to carry out drug monitoring (advice from doctors on adverse drug effects).